Hong Kong Declares CBD a Dangerous Drug

Feb.01.2023

Hong Kong Declares CBD a Dangerous Drug

CBD is now a controlled substance in Hong Kong, with potential life imprisonment and heavy fines for offenders.

As of February 1st, CBD has been officially classified as a dangerous drug and is now subject to regulation under Hong Kong's Dangerous Drugs Ordinance (Chapter 134).

Following this, the Hong Kong police force and customs department will make every effort to crackdown on drug-related offenses involving CBD.

After the law takes effect, those trafficking and illegally manufacturing CBD and its products can be sentenced to life imprisonment and fined up to HKD 5 million (approximately RMB 4.3 million). Those who possess or use the substance in violation of the Dangerous Drugs Ordinance can be sentenced to seven years in prison and fined up to HKD 1 million (approximately RMB 860,000).

The Hong Kong government previously arranged for a disposal collection of items containing CBD, allowing citizens to voluntarily dispose of them, and assisting those in need with large-scale disposals. As of January 29th, the government has collected approximately 77,400 items containing CBD, mostly skincare products, oral oils, and health supplements.

Reference:

Hong Kong is planning to completely ban the sale of CBD products by the end of 2022.

Starting tomorrow, regulations regarding cannabidiol (CBD) will be enforced and those who violate them will face legal consequences.

Hong Kong plans to ban the sale of CBD products entirely by the end of 2022.

#CBD #Hong Kong #Hong Kong, China #USA

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

China Tobacco Regulation Shift：Policy Updates and Market Impact

China Tobacco Regulation Shift：Policy Updates and Market Impact

EVO NXT European Tobacco & NGP Exhibition

EVO NXT European Tobacco & NGP Exhibition

China Tobacco International (HK) Announces FY2025 Results: Revenue Reaches HK$14.58 Billion, Up 11.5% Year-on-Year

China Tobacco International (HK) Announces FY2025 Results: Revenue Reaches HK$14.58 Billion, Up 11.5% Year-on-Year

China Tobacco International (HK) Company Limited announced its audited results for the year ended December 31, 2025. Revenue was HK$14.58 billion, profit before taxation was HK$1.28 billion, and profit attributable to owners of the Company was HK$0.98 billion, with basic and diluted EPS of HK$1.42. The Board proposed a final dividend of HK$0.33 per share; together with an interim dividend of HK$0.19 per share, the full-year dividend totaled HK$0.52 per share.

Mar.06 by 2FIRSTS.ai

Turkey’s New Tobacco Bill Draft Would Cover E-Cigarettes and Heated Tobacco Products

Turkey’s New Tobacco Bill Draft Would Cover E-Cigarettes and Heated Tobacco Products

A Turkey’s draft would impose major limits on the use of tobacco products in public buildings, educational and healthcare institutions, children’s areas, and outdoor events, while setting a 2040 target for a complete ban on the production, sale, and consumption of tobacco products. The draft also broadens the definition of tobacco products to include e-cigarettes, heated tobacco products, and all nicotine-containing systems.

Apr.13 by 2FIRSTS.ai

New York’s Lawsuit Against Puff Bar and Other Flavored Vape Companies Survives Key Court Challenge

New York’s Lawsuit Against Puff Bar and Other Flavored Vape Companies Survives Key Court Challenge

According to Law360, a federal judge ruled that makers and distributors of flavored vape brands such as Puff Bar cannot escape New York’s lawsuit seeking to hold them responsible for the youth vaping epidemic. The court found that the state had adequately alleged the companies misrepresented how safe vaping is.

Apr.07 by 2FIRSTS.ai

Fontem Sues FDA Over Refusal-to-File Decision for Nicotine Pouch PMTAs

Fontem Sues FDA Over Refusal-to-File Decision for Nicotine Pouch PMTAs

According to a complaint filed on March 17 in the U.S. District Court for the Northern District of Texas, Fontem US, LLC and Texas retailer OM Investment, LLC sued the Food and Drug Administration and the Department of Health and Human Services over FDA’s refusal-to-file decision for certain Zone nicotine pouch PMTAs.

Mar.19 by 2FIRSTS.ai

Special Report | Breeze and Glas Seek White House Review as FDA Advances Flavored ENDS Guidance

Special Report | Breeze and Glas Seek White House Review as FDA Advances Flavored ENDS Guidance

Breeze Smoke and Glas, Inc. have separately requested White House review under Executive Order 12866 as the FDA advances draft guidance on flavored ENDS (RIN 0910-ZC78). The guidance aims to clarify evidentiary standards under the statutory “appropriate for the protection of public health” (APPH) framework. The parallel filings highlight industry concern over regulatory predictability, particularly as Glas’s PMTA review status has recently drawn market attention.

Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year

Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year

FDA Center for Tobacco Products Acting Director Bret Koplow said at the American Tobacco and Nicotine Forum that the agency has reduced its premarket tobacco application backlog by about 70% over the past year and eliminated the acceptance queue. He said FDA has reviewed about 27 million applications, but only a small number have been authorized, mainly because most submissions lacked the scientific data needed to demonstrate public health benefits.

Apr.23 by 2FIRSTS.ai

Related Topics

News

Related Read

China Tobacco International (HK) Announces FY2025 Results: Revenue Reaches HK$14.58 Billion, Up 11.5% Year-on-Year

China Tobacco International (HK) Announces FY2025 Results: Revenue Reaches HK$14.58 Billion, Up 11.5% Year-on-Year

Turkey’s New Tobacco Bill Draft Would Cover E-Cigarettes and Heated Tobacco Products

Turkey’s New Tobacco Bill Draft Would Cover E-Cigarettes and Heated Tobacco Products

New York’s Lawsuit Against Puff Bar and Other Flavored Vape Companies Survives Key Court Challenge

New York’s Lawsuit Against Puff Bar and Other Flavored Vape Companies Survives Key Court Challenge

Fontem Sues FDA Over Refusal-to-File Decision for Nicotine Pouch PMTAs

Fontem Sues FDA Over Refusal-to-File Decision for Nicotine Pouch PMTAs

Special Report | Breeze and Glas Seek White House Review as FDA Advances Flavored ENDS Guidance

Special Report | Breeze and Glas Seek White House Review as FDA Advances Flavored ENDS Guidance

Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year

Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year